Publication | Closed Access

Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma – A phase II trial of the childhood liver tumour strategy group (SIOPEL)

HepatologyTumour Strategy GroupPhase Ii TrialRecurrent HepatoblastomaLiver PhysiologyMedicineHepatobiliary TumorPediatricsLiver DiseaseLiver CancerLiver TransplantationOncologyRadiation OncologyCancer ResearchHealth Sciences